Malignant neoplasm of right broad ligament
ICD-10 C57.11 is a billable code used to indicate a diagnosis of malignant neoplasm of right broad ligament.
C57.11 refers to a malignant neoplasm located in the right broad ligament, which is a peritoneal fold that extends from the sides of the uterus to the pelvic walls. This type of tumor is classified under gynecologic malignancies and can arise from various cell types, including epithelial, stromal, or germ cell origins. The broad ligament supports the uterus and contains blood vessels, nerves, and lymphatics, making it a critical area for potential tumor development. Symptoms may include pelvic pain, abnormal bleeding, or a palpable mass. Diagnosis typically involves imaging studies such as ultrasound or MRI, and histological confirmation through biopsy. Staging of the tumor is crucial for determining the extent of disease and guiding treatment options, which may include surgery, chemotherapy, or radiation therapy. The CA-125 blood test may be utilized as a tumor marker, particularly in monitoring treatment response or recurrence, although it is not specific to broad ligament tumors. Accurate coding for C57.11 requires thorough documentation of the tumor's characteristics, staging, and treatment plan.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and treatment planning for patients with suspected or confirmed broad ligament tumors.
Ensure accurate staging and histological classification to support coding.
Imaging reports detailing tumor size, location, and any associated findings.
Imaging studies performed to evaluate pelvic masses.
Clear communication of findings related to the broad ligament is essential.
Performed for malignant neoplasm of the broad ligament.
Operative report detailing the procedure and findings.
Gynecologic oncology specialists should ensure accurate coding of the procedure.
CA-125 is a tumor marker that can be elevated in patients with malignant neoplasms of the female reproductive system, including those affecting the broad ligament. It is used for monitoring treatment response and potential recurrence.
